Statute Details
- Title: Foreign Employee Dormitories (Prescribed Associates) Regulations 2022
- Act Code: FEDA2015-S706-2022
- Type: Subsidiary Legislation (SL)
- Authorising Act: Foreign Employee Dormitories Act 2015
- Enacting authority: Minister for Manpower (powers under section 34 of the Foreign Employee Dormitories Act 2015)
- Commencement: 31 August 2022
- Legislation number: SL 706/2022
- Status: Current version as at 27 March 2026
- Key provisions (as extracted): Regulations 1 to 3 (citation/commencement; prescribed associates where applicant is an individual; prescribed associates where applicant is a body corporate)
What Is This Legislation About?
The Foreign Employee Dormitories (Prescribed Associates) Regulations 2022 (“Prescribed Associates Regulations”) are subsidiary legislation made under the Foreign Employee Dormitories Act 2015 (“FEDA”). In practical terms, the Regulations clarify who counts as an “associate” of an applicant for the purposes of the Act—particularly where the applicant seeks approval or is subject to regulatory scrutiny under FEDA.
FEDA regulates the provision and management of foreign employee dormitories in Singapore. A recurring theme in dormitory regulation is that the regulator must be able to assess not only the applicant entity or individual, but also persons or entities that are connected to the applicant through control, influence, ownership, or close personal relationships. This is because such associates may affect governance, compliance posture, and the risk profile of the dormitory operator or applicant.
The Prescribed Associates Regulations therefore “fill in the blanks” in the Act by prescribing detailed categories of associates. The Regulations distinguish between applicants who are individuals and applicants who are body corporates, and they set out structured tests for when a person or entity is treated as an associate—using concepts such as relatives/spouses, partnership, control, significant interest, and corporate relationships like subsidiaries and holding companies.
What Are the Key Provisions?
Regulation 1: Citation and commencement. This is the formal commencement provision. The Regulations are cited as the Foreign Employee Dormitories (Prescribed Associates) Regulations 2022 and come into operation on 31 August 2022. For practitioners, this matters for determining which version applies to applications, compliance steps, or events occurring around that date.
Regulation 2: Prescribed associates where the applicant is an individual. Regulation 2 implements the “associate” concept for the scenario where the applicant (denoted as A) is an individual. It is expressly made “for the purposes of section 9(4) of the Act.” Although the extract does not reproduce section 9(4), the structure indicates that section 9(4) requires the regulator to consider associates of an individual applicant.
Under Regulation 2(1)(a), an individual B is an associate of A if any of the following apply:
- Relative/spouse relationship: B is a relative, or spouse of a relative, of A or of A’s spouse.
- Partnership: B is in partnership with A.
- Indirect partnership via relatives: A is the relative of any other person with whom B is in partnership, or B is the relative of any other person with whom A is in partnership.
- Control: B has control over A.
Regulation 2(1)(b) further provides that an entity C is an associate of A if A is or was a company director, managing director, chief executive officer, manager, partner or sole proprietor of C. This is a governance-and-management link: it captures formal roles that typically correlate with decision-making authority or operational influence.
Regulation 2(2): Definitions and interpretive rules. The Regulations include several important interpretive clarifications:
- “Relative” definition: “relative” takes the meaning in section 2(1) of the Act.
- Former spouse included: any reference to a spouse includes a former spouse. This prevents parties from avoiding associate status by relying on relationship termination.
- Control test (individual context): for Regulation 2(1)(a)(iv), B is taken to have control over A if A is accustomed to act in accordance with B’s directions or instructions. This is a “de facto control” concept—focused on habitual compliance with another’s directions.
- “Entity” definition: “entity” includes any sole proprietorship, partnership, or body corporate, with or without limited liability. This ensures breadth across business forms.
Regulation 3: Prescribed associates where the applicant is a body corporate. Regulation 3 applies when the applicant D is a body corporate. Like Regulation 2, it is made “for the purposes of section 9(4) of the Act.” The provision is more complex because it addresses both (i) individuals associated with the body corporate and (ii) other body corporates associated with it.
Under Regulation 3(1)(a), an individual E is an associate of D if any of the following apply:
- Control: E has control over D, or E and persons who are E’s associates together have control over D.
- Significant interest: E has a significant interest in D, or E and persons who are E’s associates together have a significant interest in D.
- Management/board role links: E is or was a company director, managing director, chief executive officer or manager of D or of D’s subsidiary or holding company.
Under Regulation 3(1)(b), a body corporate F is an associate of D if any of the following apply:
- Control: F has control over D, or F and persons who are F’s associates together have control over D.
- Significant interest: F has a significant interest in D, or F and persons who are F’s associates together have a significant interest in D.
- Corporate group relationships: F is a subsidiary of D, or F is the holding company of D.
Regulation 3(2): Subsidiary and holding company definitions. “Subsidiary” and “holding company” take their meanings from section 5 of the Companies Act 1967. This is a key cross-reference: it anchors the dormitory associate analysis to established corporate law definitions.
Regulation 3(3): Control test (corporate context). For the control limbs in Regulation 3(1)(a)(i) and 3(1)(b)(i), the Regulations provide a multi-part test. E or F is taken to have control of D if:
- De facto direction: the directors of D (or directors of another body corporate which has control of D, or any of those directors) are accustomed to act in accordance with E’s or F’s directions or instructions.
- Appointment/removal rights: E or F holds the right (directly or indirectly) to appoint or remove directors (or equivalent persons) of D who hold a majority of voting rights at directors’ meetings on all or substantially all matters.
- Voting power threshold: E or F is entitled to exercise, or control the exercise of, 25% or more of the voting power at any general meeting of D or of another body corporate which has control of D.
The Regulations also address aggregation: where two or more persons together satisfy any of the sub-paragraphs, they are taken to have control of D. This is important for complex shareholding structures and joint influence arrangements.
Regulation 3(4): Significant interest test (corporate context). For the significant interest limbs in Regulation 3(1)(a)(ii) and 3(1)(b)(ii), the Regulations set out thresholds that depend on whether the body corporate has share capital.
If D has share capital, E or F has a significant interest if:
- Shareholding threshold: it has an interest in more than 25% of the shares in D; or
- Voting shares threshold: it has an interest in one or more voting shares where the total votes attached to those shares are more than 25% of the total voting power.
If D does not have share capital, significant interest exists if E or F holds, whether directly or indirectly, a right to share in more than 25% of the capital or more than 25% of the profits of D.
Again, the Regulations include aggregation: where two or more persons together satisfy the relevant sub-paragraphs, they are taken to have a significant interest.
How Is This Legislation Structured?
The Regulations are structured as a short instrument with a straightforward layout:
- Regulation 1 sets out the citation and commencement date.
- Regulation 2 prescribes associates where the applicant is an individual, including relatives/spouses, partnership links, de facto control, and management/role-based links to entities.
- Regulation 3 prescribes associates where the applicant is a body corporate, including individual associates (control, significant interest, and management roles) and corporate associates (control, significant interest, and subsidiary/holding relationships), supported by detailed control and significant interest tests.
In effect, the instrument functions as a definitional and interpretive framework rather than a regulatory compliance code with licensing steps. Its operational impact is felt through how “associate” status is determined under the underlying FEDA scheme.
Who Does This Legislation Apply To?
The Regulations apply to situations where an applicant under the Foreign Employee Dormitories Act 2015 is either (i) an individual or (ii) a body corporate. They are not aimed at dormitory residents or employees; rather, they target the applicant side of the regulatory process.
Practically, the Regulations will be relevant to dormitory operators, prospective applicants, and their advisers—because the associate analysis can affect eligibility, disclosure obligations, and the regulator’s assessment of governance and influence. The Regulations also capture associates beyond the applicant’s immediate corporate structure by including relatives/spouses and partnership relationships for individual applicants, and by including both individuals and other corporate entities for corporate applicants.
Why Is This Legislation Important?
Although the Prescribed Associates Regulations are brief, they are legally significant because they determine the scope of persons and entities that must be treated as “associates” for the purposes of section 9(4) of FEDA. In regulated sectors, the definition of “associate” often drives downstream consequences—such as whether certain persons are considered connected parties, whether information must be disclosed, and how the regulator evaluates risk and suitability.
From a practitioner’s perspective, the Regulations provide clear, threshold-based tests for corporate influence: control includes de facto direction, appointment/removal rights, and a 25% voting power threshold; significant interest includes ownership or voting power exceeding 25%, or profit/capital sharing exceeding 25% where there is no share capital. These are quantifiable standards that can be mapped onto shareholding registers, board appointment arrangements, shareholder agreements, and group structures.
The Regulations also include anti-avoidance features: former spouses are included; control is assessed based on habitual compliance with directions; and aggregation provisions ensure that joint influence through multiple associates cannot be ignored. For legal teams advising dormitory applicants, this means associate mapping should be done systematically—covering not only direct relationships but also indirect and aggregated influence.
Related Legislation
- Foreign Employee Dormitories Act 2015
- Companies Act 1967 (for definitions of “subsidiary” and “holding company”)
Source Documents
This article provides an overview of the Foreign Employee Dormitories (Prescribed Associates) Regulations 2022 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.